14 completed. 14 Phase 3, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 14 |
| Phase 2 | 6 | Completed 6 |
Follow Trypanosomiasis: new trials by email Literature Review of Trypanosomiasis trials Research Report on Trypanosomiasis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients Acoziborole - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 35 | 2022-07-09 | 2026-04-06 |
| Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects Acoziborole, Placebo - Trypanosomiasis, African, Trypanosoma Brucei Gambiense; Infection | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 1208 | 2021-12-30 | 2025-03-20 |
| Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense Fexinidazole - Trypanosomiasis, African, Sleeping Sickness | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 45 | 2019-09-29 | 2025-01-30 |
| Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age Benznidazole, Placebo Oral Tablet - Chagas Disease | Phase 3 | Completed | Tulane University School of Public Health and Tropical Medicine | 87 | 2019-06-01 | 2026-04-09 |
| Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage Fexinidazole - Trypanosomiasis, African, Sleeping Sickness | Phase 3 | Completed | Drugs for Neglected Diseases | 174 | 2016-11-10 | 2025-01-08 |
| Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gambiense Acoziborole - Trypanosomiasis, African, Gambiense Trypanosomiasis | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 208 | 2016-10-11 | 2025-09-17 |
| A Study to Learn How Well Nifurtimox Works and How Safe it is in Children Aged 0 to 17 Years With Chagas' Disease, an Inflammatory, Infectious Disease Caused by the Parasite Trypanosoma Cruzi Nifurtimox (Lampit, BAYA2502), Placebo - Chagas Disease | Phase 3 | Completed | Bayer | 330 | 2016-01-27 | 2024-08-19 |
| Physical Exercise Program in Chronic Chagas Heart Disease Exercise, nutritional and pharmaceutical counceling, Nutritional and pharmaceutical counceling - Chagas Disease, Chagas Cardiomyopathy | Phase 3 | Completed | Evandro Chagas National Institute of Infectious Disease | 30 | 2015-03-01 | 2017-07-27 |
| Cardiac Rehabilitation in Chagas Heart Failure Exercise, nutritional and pharmaceutical counseling - Chagas Disease, Chagas Cardiomyopathy | Phase 2 / Phase 3 | Completed | Evandro Chagas National Institute of Infectious Disease | 12 | 2013-05-01 | 2015-08-05 |
| Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2 Fexinidazole, Nifurtimox, Eflornithine - Human African Trypanosomiasis (HAT), Sleeping Sickness | Phase 2 / Phase 3 | Completed | Drugs for Neglected Diseases | 394 | 2012-10-01 | 2018-02-20 |
| BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease Benznidazole, Placebo - Chagas Disease, Trypanosomiasis | Phase 3 | Completed | Population Health Research Institute | 2854 | 2004-11-01 | 2020-03-03 |
| Chagas Cardiomyopathy Bisoprolol Intervention Study: Charity Bisoprolol - Chagas Cardiomyopathy, Chronic Heart Failure | Phase 3 | Completed | Fundación Cardiovascular de Colombia | 500 | 2003-07-01 | 2010-11-24 |
| Etiologic Treatment With Benznidazole in Adult Patients With Chronic Chagas Disease. A Randomized Clinical Trial Benznidazole, Placebo - Chagas Disease | Phase 3 | Completed | Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben | 910 | 1999-03-01 | 2015-03-11 |
| Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis Eflornithine, Nifurtimox - Trypanosomiasis, African | Phase 3 | Completed | Drugs for Neglected Diseases | 280 | 2016-09-29 |
Trypanosomiasis, African (7) · Chagas Disease (6) · Chagas Cardiomyopathy (3) · Infections (3) · Heart Diseases (1) · Heart Failure (1) · Motor Activity (1) · Neglected Diseases (1)
Euglenozoa Infections (14) · Parasitic Diseases (14) · Protozoan Infections (14) · Vector Borne Diseases (14) · Infections (11) · Cardiovascular Diseases (4) · Cardiomyopathies (3) · Heart Diseases (3) · Behavior (1) · Chagas Disease (1) · Disease Attributes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Nifurtimox (3) · benzonidazole (3) · fexinidazole (3) · Eflornithine (2) · Exercise (2) · Bisoprolol (1) · SCYX 7158 (1)
Drugs for Neglected Diseases (7) · Evandro Chagas National Institute of Infectious Disease (2) · Bayer (1) · Fundación Cardiovascular de Colombia (1) · Instituto Nacional de Parasitologia Dr. Mario Fatala Chaben (1) · Population Health Research Institute (1) · Tulane University School of Public Health and Tropical Medicine (1)
Democratic Republic of the Congo (6) · Argentina (4) · Guinea (4) · Brazil (3) · Colombia (3) · Bolivia (2) · Republic of the Congo (2) · Central African Republic (1) · El Salvador (1) · Malawi (1) · Uganda (1) · United States (1)
Adellina R Riarte, MD (1) · Andrea S Sousa, PhD (1) · Carlos A Morillo, MD, FRCPC (1) · Carlos Morillo, MD (1) · Digas Ngolo Tete, MPH (1) · Els Torreele, PhD (1) · Enock Matovu, Prof (1) · Fernanda Mendes, M.D. (1) · Fernando Rosas, M.D. (1) · Gerardo Priotto, MD, MPH (1) · Jose Antonio Marin-Neto, MD, PhD (1) · Mamadou Camara, PhD (1) · Pierre Buekens, MD, PhD (1)
PMID 8937280, PMID 9790423, PMID 16235350, PMID 16702588, PMID 19559476, PMID 19753491, PMID 21264349, PMID 24867876, PMID 26323937, PMID 27590681, PMID 29113731, PMID 32831069, PMID 33412557, PMID 36460027, PMID 36975790, PMID 37352322, PMID 3835868, PMID 38589582, PMID 40288399, PMID 40288400, PMID 8273735, PMID 8948328